While the industry obsesses over faster chips and bigger context windows, AlixPartners consultant Kevin Madura argues the real disruption ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
IntroductionIn June 2026, Zscaler ThreatLabz identified a new malware family, tracked as SloppyRAT, that is likely leveraged by a ransomware-related threat actor. ThreatLabz observed SloppyRAT being ...
The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...
John Schulman, Beren Millidge, and Charlie O'Neill — sat down with Dwarkesh Patel to argue about why 2036 might ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results